Skip to content

Clinical trials

Phase 2 Colitis, Ulcerative trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 2 Country / region: Japan Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20131
20151
20182
20192
20202
20214
20225
20236
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting10
Terminated8
Recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Sanofi4
AstraZeneca3
Pfizer3
Amgen2
Bristol-Myers Squibb2
Janssen Research & Development, LLC2
Otsuka Pharmaceutical Co., Ltd.2
AbbVie1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative36
Colitis3
Crohn Disease3
Inflammatory Bowel Diseases3
Colonic Diseases1
Digestive System Diseases1
Gastrointestinal Diseases1
Intestinal Diseases1
Ulcer1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.